Review





Similar Products

94
Zymo Research quick dna rna pathogen miniprep kit
(A) Schematic overview of the protocol modifications incorporated into Rapid-RPIP v1 relative to the Standard RPIP workflow. Individual optimisation steps, selected to reduce turnaround time, and their estimated time savings are shown. (B) Relative abundance (%) of the ten ZymoBIOMICS-DNA/RNA mock community organisms recovered by two extraction methods <t>(Quick-DNA/RNA,</t> ZymoBIOMICS-DNA/RNA; mean of 2 replicates each) compared with the manufacturer theoretical composition. (C) RPKM concordance between standard and rapid cDNA synthesis protocols for RNA respiratory viruses (n = 6 organism–sample pairs). Dashed line: identity (y = x); solid line: linear regression with 95% CI. Spearman ρ and Pearson r (log₁₀-RPKM) annotated. (D) Coefficient of variation (log₁₀ scale) of RPKM values across three hybridisation times (30/60/90 min), grouped by pathogen type (Bacteria, RNA Virus, DNA Virus); n per group annotated.
Quick Dna Rna Pathogen Miniprep Kit, supplied by Zymo Research, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pathogens/Quick-DNA%2FRNA+Pathogen+Miniprep/med_rxiv__64898__2026__10__09__26365131-50-16-20
Average 94 stars, based on 1 article reviews
quick dna rna pathogen miniprep kit - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

99
Envigo pathogen free c57bl 6j olahsd immune competent female mice
(A) Schematic overview of the protocol modifications incorporated into Rapid-RPIP v1 relative to the Standard RPIP workflow. Individual optimisation steps, selected to reduce turnaround time, and their estimated time savings are shown. (B) Relative abundance (%) of the ten ZymoBIOMICS-DNA/RNA mock community organisms recovered by two extraction methods <t>(Quick-DNA/RNA,</t> ZymoBIOMICS-DNA/RNA; mean of 2 replicates each) compared with the manufacturer theoretical composition. (C) RPKM concordance between standard and rapid cDNA synthesis protocols for RNA respiratory viruses (n = 6 organism–sample pairs). Dashed line: identity (y = x); solid line: linear regression with 95% CI. Spearman ρ and Pearson r (log₁₀-RPKM) annotated. (D) Coefficient of variation (log₁₀ scale) of RPKM values across three hybridisation times (30/60/90 min), grouped by pathogen type (Bacteria, RNA Virus, DNA Virus); n per group annotated.
Pathogen Free C57bl 6j Olahsd Immune Competent Female Mice, supplied by Envigo, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pathogens/C57BL%2F6+aged+inbred+mice/10__22203_slash_ecm__v033a11-101-1-8
Average 99 stars, based on 1 article reviews
pathogen free c57bl 6j olahsd immune competent female mice - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
Inotiv pathogen free spf c57bl 6
ABXs can promote HCC in vivo and reshape the myeloid liver tumor immune microenvironment in tumors presenting OVA model antigens. (A) Schematic of the experimental design of in vivo ABXs treatment experiments performed in C57BL/6 WT mice. Generated by BioRender. (B) Quantification of MYC-lucOS;CTNNB1 macroscopic tumors in the livers of the 5 indicated treatment groups at 3 weeks. In the right panel, representative pictures of the mouse livers. Scale bars, 1 cm. (C) Liver-to-body weight ratio of the 5 treatment groups. (D) Survival curve in mice harboring MYC-lucOS;CTNNB1 tumors treated with vancomycin or without treatment (Ctrl). (E) Quantification of the number of myeloid subpopulations including Kupffer cells (KCs), monocytes, Mono/Macs, tumor-associated macrophages (TAMs), total dendritic cells (DCs), cDC1, and cDC2 in the livers of the corresponding mice (n=4–5 per group). (F) Quantification of MYC-luc;CTNNB1 macroscopic tumors in the livers of the 5 indicated treatment groups at 3 weeks. In the right panel, representative pictures of the mouse livers. Scale bars, 1 cm. (G) Liver-to-body weight ratio of the 5 treatment groups. (H) Survival curve in mice harboring MYC-luc;CTNNB1 tumors treated with vancomycin or without treatment (Ctrl). Abbreviations: ABXs, antibiotics; DCs, dendritic cells; HCC, hepatocellular carcinoma; HDTVI, hydrodynamic tail-vein injection; KCs, Kupffer cells; Mono/Mac, monocyte/macrophage; OVA, ovalbumin; TAMS, tumor-associated macrophages; WT, wild type.
Pathogen Free Spf C57bl 6, supplied by Inotiv, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pathogens/C57BL%2F6+Mouse/pmc13766593-54-1-11
Average 99 stars, based on 1 article reviews
pathogen free spf c57bl 6 - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

90
ATCC non pathogenic strain s epidermidis atcc
ABXs can promote HCC in vivo and reshape the myeloid liver tumor immune microenvironment in tumors presenting OVA model antigens. (A) Schematic of the experimental design of in vivo ABXs treatment experiments performed in C57BL/6 WT mice. Generated by BioRender. (B) Quantification of MYC-lucOS;CTNNB1 macroscopic tumors in the livers of the 5 indicated treatment groups at 3 weeks. In the right panel, representative pictures of the mouse livers. Scale bars, 1 cm. (C) Liver-to-body weight ratio of the 5 treatment groups. (D) Survival curve in mice harboring MYC-lucOS;CTNNB1 tumors treated with vancomycin or without treatment (Ctrl). (E) Quantification of the number of myeloid subpopulations including Kupffer cells (KCs), monocytes, Mono/Macs, tumor-associated macrophages (TAMs), total dendritic cells (DCs), cDC1, and cDC2 in the livers of the corresponding mice (n=4–5 per group). (F) Quantification of MYC-luc;CTNNB1 macroscopic tumors in the livers of the 5 indicated treatment groups at 3 weeks. In the right panel, representative pictures of the mouse livers. Scale bars, 1 cm. (G) Liver-to-body weight ratio of the 5 treatment groups. (H) Survival curve in mice harboring MYC-luc;CTNNB1 tumors treated with vancomycin or without treatment (Ctrl). Abbreviations: ABXs, antibiotics; DCs, dendritic cells; HCC, hepatocellular carcinoma; HDTVI, hydrodynamic tail-vein injection; KCs, Kupffer cells; Mono/Mac, monocyte/macrophage; OVA, ovalbumin; TAMS, tumor-associated macrophages; WT, wild type.
Non Pathogenic Strain S Epidermidis Atcc, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pathogens/Ostracoblabe+implexa+Bornet+et+Flahault/pm42983663-21-1-5
Average 90 stars, based on 1 article reviews
non pathogenic strain s epidermidis atcc - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

94
DSMZ bacterial strains bacterial strain description source pectobacterium carotovorum subsp carotovorum pcc21 soft rot pathogen
ABXs can promote HCC in vivo and reshape the myeloid liver tumor immune microenvironment in tumors presenting OVA model antigens. (A) Schematic of the experimental design of in vivo ABXs treatment experiments performed in C57BL/6 WT mice. Generated by BioRender. (B) Quantification of MYC-lucOS;CTNNB1 macroscopic tumors in the livers of the 5 indicated treatment groups at 3 weeks. In the right panel, representative pictures of the mouse livers. Scale bars, 1 cm. (C) Liver-to-body weight ratio of the 5 treatment groups. (D) Survival curve in mice harboring MYC-lucOS;CTNNB1 tumors treated with vancomycin or without treatment (Ctrl). (E) Quantification of the number of myeloid subpopulations including Kupffer cells (KCs), monocytes, Mono/Macs, tumor-associated macrophages (TAMs), total dendritic cells (DCs), cDC1, and cDC2 in the livers of the corresponding mice (n=4–5 per group). (F) Quantification of MYC-luc;CTNNB1 macroscopic tumors in the livers of the 5 indicated treatment groups at 3 weeks. In the right panel, representative pictures of the mouse livers. Scale bars, 1 cm. (G) Liver-to-body weight ratio of the 5 treatment groups. (H) Survival curve in mice harboring MYC-luc;CTNNB1 tumors treated with vancomycin or without treatment (Ctrl). Abbreviations: ABXs, antibiotics; DCs, dendritic cells; HCC, hepatocellular carcinoma; HDTVI, hydrodynamic tail-vein injection; KCs, Kupffer cells; Mono/Mac, monocyte/macrophage; OVA, ovalbumin; TAMS, tumor-associated macrophages; WT, wild type.
Bacterial Strains Bacterial Strain Description Source Pectobacterium Carotovorum Subsp Carotovorum Pcc21 Soft Rot Pathogen, supplied by DSMZ, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pathogens/Pectobacterium+carotovorum/10__5423_slash_ppj__oa__08__2026__0123-81-0-41
Average 94 stars, based on 1 article reviews
bacterial strains bacterial strain description source pectobacterium carotovorum subsp carotovorum pcc21 soft rot pathogen - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

99
Inotiv specific pathogen free cba caolahsd cba
ABXs can promote HCC in vivo and reshape the myeloid liver tumor immune microenvironment in tumors presenting OVA model antigens. (A) Schematic of the experimental design of in vivo ABXs treatment experiments performed in C57BL/6 WT mice. Generated by BioRender. (B) Quantification of MYC-lucOS;CTNNB1 macroscopic tumors in the livers of the 5 indicated treatment groups at 3 weeks. In the right panel, representative pictures of the mouse livers. Scale bars, 1 cm. (C) Liver-to-body weight ratio of the 5 treatment groups. (D) Survival curve in mice harboring MYC-lucOS;CTNNB1 tumors treated with vancomycin or without treatment (Ctrl). (E) Quantification of the number of myeloid subpopulations including Kupffer cells (KCs), monocytes, Mono/Macs, tumor-associated macrophages (TAMs), total dendritic cells (DCs), cDC1, and cDC2 in the livers of the corresponding mice (n=4–5 per group). (F) Quantification of MYC-luc;CTNNB1 macroscopic tumors in the livers of the 5 indicated treatment groups at 3 weeks. In the right panel, representative pictures of the mouse livers. Scale bars, 1 cm. (G) Liver-to-body weight ratio of the 5 treatment groups. (H) Survival curve in mice harboring MYC-luc;CTNNB1 tumors treated with vancomycin or without treatment (Ctrl). Abbreviations: ABXs, antibiotics; DCs, dendritic cells; HCC, hepatocellular carcinoma; HDTVI, hydrodynamic tail-vein injection; KCs, Kupffer cells; Mono/Mac, monocyte/macrophage; OVA, ovalbumin; TAMS, tumor-associated macrophages; WT, wild type.
Specific Pathogen Free Cba Caolahsd Cba, supplied by Inotiv, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pathogens/C57BL%2F6+Mouse/pm42980774-29-5-12
Average 99 stars, based on 1 article reviews
specific pathogen free cba caolahsd cba - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

94
DSMZ fungal pathogens botrytis cinerea
ABXs can promote HCC in vivo and reshape the myeloid liver tumor immune microenvironment in tumors presenting OVA model antigens. (A) Schematic of the experimental design of in vivo ABXs treatment experiments performed in C57BL/6 WT mice. Generated by BioRender. (B) Quantification of MYC-lucOS;CTNNB1 macroscopic tumors in the livers of the 5 indicated treatment groups at 3 weeks. In the right panel, representative pictures of the mouse livers. Scale bars, 1 cm. (C) Liver-to-body weight ratio of the 5 treatment groups. (D) Survival curve in mice harboring MYC-lucOS;CTNNB1 tumors treated with vancomycin or without treatment (Ctrl). (E) Quantification of the number of myeloid subpopulations including Kupffer cells (KCs), monocytes, Mono/Macs, tumor-associated macrophages (TAMs), total dendritic cells (DCs), cDC1, and cDC2 in the livers of the corresponding mice (n=4–5 per group). (F) Quantification of MYC-luc;CTNNB1 macroscopic tumors in the livers of the 5 indicated treatment groups at 3 weeks. In the right panel, representative pictures of the mouse livers. Scale bars, 1 cm. (G) Liver-to-body weight ratio of the 5 treatment groups. (H) Survival curve in mice harboring MYC-luc;CTNNB1 tumors treated with vancomycin or without treatment (Ctrl). Abbreviations: ABXs, antibiotics; DCs, dendritic cells; HCC, hepatocellular carcinoma; HDTVI, hydrodynamic tail-vein injection; KCs, Kupffer cells; Mono/Mac, monocyte/macrophage; OVA, ovalbumin; TAMS, tumor-associated macrophages; WT, wild type.
Fungal Pathogens Botrytis Cinerea, supplied by DSMZ, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pathogens/Botrytis+cinerea/pm42913464-47-1-33
Average 94 stars, based on 1 article reviews
fungal pathogens botrytis cinerea - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

99
ATCC human pathogenic microorganisms bacillus subtilis
Biological properties of dictamnine.
Human Pathogenic Microorganisms Bacillus Subtilis, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pathogens/Bacillus+spizizenii+(Nakamura+et+al%2E)+Dunlap+et+al/pmc13765392-101-2-7
Average 99 stars, based on 1 article reviews
human pathogenic microorganisms bacillus subtilis - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
ATCC antimicrobial activity against pathogenic bacteria
Biological properties of dictamnine.
Antimicrobial Activity Against Pathogenic Bacteria, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pathogens/Escherichia+coli+(Migula)+Castellani+and+Chalmers/10__1038_slash_s41598___026___76824___y-77-0-16
Average 99 stars, based on 1 article reviews
antimicrobial activity against pathogenic bacteria - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

97
Bio-Rad western ecl substrate plos pathogens
Biological properties of dictamnine.
Western Ecl Substrate Plos Pathogens, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pathogens/Clarity+Max+Western+ECL+Substrate/pm42868206-236-13-12
Average 97 stars, based on 1 article reviews
western ecl substrate plos pathogens - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

Image Search Results


(A) Schematic overview of the protocol modifications incorporated into Rapid-RPIP v1 relative to the Standard RPIP workflow. Individual optimisation steps, selected to reduce turnaround time, and their estimated time savings are shown. (B) Relative abundance (%) of the ten ZymoBIOMICS-DNA/RNA mock community organisms recovered by two extraction methods (Quick-DNA/RNA, ZymoBIOMICS-DNA/RNA; mean of 2 replicates each) compared with the manufacturer theoretical composition. (C) RPKM concordance between standard and rapid cDNA synthesis protocols for RNA respiratory viruses (n = 6 organism–sample pairs). Dashed line: identity (y = x); solid line: linear regression with 95% CI. Spearman ρ and Pearson r (log₁₀-RPKM) annotated. (D) Coefficient of variation (log₁₀ scale) of RPKM values across three hybridisation times (30/60/90 min), grouped by pathogen type (Bacteria, RNA Virus, DNA Virus); n per group annotated.

Journal: medRxiv

Article Title: Same-day hybrid capture workflow for diagnosis and surveillance of respiratory pathogens

doi: 10.64898/2026.10.09.26365131

Figure Lengend Snippet: (A) Schematic overview of the protocol modifications incorporated into Rapid-RPIP v1 relative to the Standard RPIP workflow. Individual optimisation steps, selected to reduce turnaround time, and their estimated time savings are shown. (B) Relative abundance (%) of the ten ZymoBIOMICS-DNA/RNA mock community organisms recovered by two extraction methods (Quick-DNA/RNA, ZymoBIOMICS-DNA/RNA; mean of 2 replicates each) compared with the manufacturer theoretical composition. (C) RPKM concordance between standard and rapid cDNA synthesis protocols for RNA respiratory viruses (n = 6 organism–sample pairs). Dashed line: identity (y = x); solid line: linear regression with 95% CI. Spearman ρ and Pearson r (log₁₀-RPKM) annotated. (D) Coefficient of variation (log₁₀ scale) of RPKM values across three hybridisation times (30/60/90 min), grouped by pathogen type (Bacteria, RNA Virus, DNA Virus); n per group annotated.

Article Snippet: To this end, the ZymoBIOMICS DNA/RNA Miniprep Kit for nucleic acid extraction was replaced with the Quick-DNA/RNA Pathogen Miniprep Kit (Zymo Research, R1042), and samples were processed according to the manufacturer’s instructions.

Techniques: Extraction, cDNA Synthesis, Hybridization, Bacteria, Virus

ABXs can promote HCC in vivo and reshape the myeloid liver tumor immune microenvironment in tumors presenting OVA model antigens. (A) Schematic of the experimental design of in vivo ABXs treatment experiments performed in C57BL/6 WT mice. Generated by BioRender. (B) Quantification of MYC-lucOS;CTNNB1 macroscopic tumors in the livers of the 5 indicated treatment groups at 3 weeks. In the right panel, representative pictures of the mouse livers. Scale bars, 1 cm. (C) Liver-to-body weight ratio of the 5 treatment groups. (D) Survival curve in mice harboring MYC-lucOS;CTNNB1 tumors treated with vancomycin or without treatment (Ctrl). (E) Quantification of the number of myeloid subpopulations including Kupffer cells (KCs), monocytes, Mono/Macs, tumor-associated macrophages (TAMs), total dendritic cells (DCs), cDC1, and cDC2 in the livers of the corresponding mice (n=4–5 per group). (F) Quantification of MYC-luc;CTNNB1 macroscopic tumors in the livers of the 5 indicated treatment groups at 3 weeks. In the right panel, representative pictures of the mouse livers. Scale bars, 1 cm. (G) Liver-to-body weight ratio of the 5 treatment groups. (H) Survival curve in mice harboring MYC-luc;CTNNB1 tumors treated with vancomycin or without treatment (Ctrl). Abbreviations: ABXs, antibiotics; DCs, dendritic cells; HCC, hepatocellular carcinoma; HDTVI, hydrodynamic tail-vein injection; KCs, Kupffer cells; Mono/Mac, monocyte/macrophage; OVA, ovalbumin; TAMS, tumor-associated macrophages; WT, wild type.

Journal: Hepatology Communications

Article Title: Bacteroidetes promote hepatocellular carcinoma progression and resistance to immunotherapy

doi: 10.1097/HC9.0000000000001086

Figure Lengend Snippet: ABXs can promote HCC in vivo and reshape the myeloid liver tumor immune microenvironment in tumors presenting OVA model antigens. (A) Schematic of the experimental design of in vivo ABXs treatment experiments performed in C57BL/6 WT mice. Generated by BioRender. (B) Quantification of MYC-lucOS;CTNNB1 macroscopic tumors in the livers of the 5 indicated treatment groups at 3 weeks. In the right panel, representative pictures of the mouse livers. Scale bars, 1 cm. (C) Liver-to-body weight ratio of the 5 treatment groups. (D) Survival curve in mice harboring MYC-lucOS;CTNNB1 tumors treated with vancomycin or without treatment (Ctrl). (E) Quantification of the number of myeloid subpopulations including Kupffer cells (KCs), monocytes, Mono/Macs, tumor-associated macrophages (TAMs), total dendritic cells (DCs), cDC1, and cDC2 in the livers of the corresponding mice (n=4–5 per group). (F) Quantification of MYC-luc;CTNNB1 macroscopic tumors in the livers of the 5 indicated treatment groups at 3 weeks. In the right panel, representative pictures of the mouse livers. Scale bars, 1 cm. (G) Liver-to-body weight ratio of the 5 treatment groups. (H) Survival curve in mice harboring MYC-luc;CTNNB1 tumors treated with vancomycin or without treatment (Ctrl). Abbreviations: ABXs, antibiotics; DCs, dendritic cells; HCC, hepatocellular carcinoma; HDTVI, hydrodynamic tail-vein injection; KCs, Kupffer cells; Mono/Mac, monocyte/macrophage; OVA, ovalbumin; TAMS, tumor-associated macrophages; WT, wild type.

Article Snippet: Specific pathogen-free (SPF) C57BL/6 wild-type mice of 4–6-week-old were purchased from Envigo.

Techniques: In Vivo, Generated, Injection

Parabacteroides distasonis promotes HCC in mice harboring tumors with OVA model antigens. (A) Heatmap plot of average % OTU Bacteroidetes species in ctrl and vancomycin-treated mice stools. (B) Schematic of the experimental design of the in vivo colonization with P. distasonis experiment performed in C57BL/6 WT mice. Generated by BioRender. Survival curve in SPF mice pre-treated with ABXs, colonized with P. distasonis or PBS (Ctrl-group) by oral gavage and harboring MYC-lucOS;CTNNB1 (C) or MYC-luc;CTNNB1 (D) tumors. Abbreviations: ABXs, antibiotics; FMT, fecal microbiome transplant; HCC, hepatocellular carcinoma; HDTVI, hydrodynamic tail-vein injection; OTU, operational taxonomic unit; OVA, ovalbumin; PBS, phosphate-buffered saline; PBS-FMT, phosphate-buffered saline–fecal microbiome transplantation; SPF, specific pathogen-free; WT, wild type.

Journal: Hepatology Communications

Article Title: Bacteroidetes promote hepatocellular carcinoma progression and resistance to immunotherapy

doi: 10.1097/HC9.0000000000001086

Figure Lengend Snippet: Parabacteroides distasonis promotes HCC in mice harboring tumors with OVA model antigens. (A) Heatmap plot of average % OTU Bacteroidetes species in ctrl and vancomycin-treated mice stools. (B) Schematic of the experimental design of the in vivo colonization with P. distasonis experiment performed in C57BL/6 WT mice. Generated by BioRender. Survival curve in SPF mice pre-treated with ABXs, colonized with P. distasonis or PBS (Ctrl-group) by oral gavage and harboring MYC-lucOS;CTNNB1 (C) or MYC-luc;CTNNB1 (D) tumors. Abbreviations: ABXs, antibiotics; FMT, fecal microbiome transplant; HCC, hepatocellular carcinoma; HDTVI, hydrodynamic tail-vein injection; OTU, operational taxonomic unit; OVA, ovalbumin; PBS, phosphate-buffered saline; PBS-FMT, phosphate-buffered saline–fecal microbiome transplantation; SPF, specific pathogen-free; WT, wild type.

Article Snippet: Specific pathogen-free (SPF) C57BL/6 wild-type mice of 4–6-week-old were purchased from Envigo.

Techniques: In Vivo, Generated, Microbiome, Injection, Saline, Transplantation Assay

Fecal microbiome transplant with human microbiota enriched in Bacteroidetes promotes HCC in mice harboring tumors with OVA model antigens. (A) Taxonomic plots of phylum relative abundance (%) composition from patients’ stools collected from NR-1025 (left) and R-1014 (right) subjects from HCC “cohort A.” (B) Schematic of experiment design of survival experiments on either C57BL6 WT GF or SPF mice pre-depleted with ABXs harboring MYC-lucOS;CTNNB1 tumors after FMT with blended stool generated from an R-donor (1014 subject) and an NR-donor (1025 subject). Schematic generated by BioRender. Survival curves from ex-GF mice harboring MYC-lucOS;CTNNB1 (C) or MYC-luc;CTNNB1 (D) tumors upon FMT with 1025-stool or 1014-stool. Abbreviations: ABXs, antibiotics; FMT, fecal microbiome transplant; GF, germ-free; HCC, hepatocellular carcinoma; HDTVI, hydrodynamic tail-vein injection; OVA, ovalbumin; SPF, specific pathogen-free; WT, wild type.

Journal: Hepatology Communications

Article Title: Bacteroidetes promote hepatocellular carcinoma progression and resistance to immunotherapy

doi: 10.1097/HC9.0000000000001086

Figure Lengend Snippet: Fecal microbiome transplant with human microbiota enriched in Bacteroidetes promotes HCC in mice harboring tumors with OVA model antigens. (A) Taxonomic plots of phylum relative abundance (%) composition from patients’ stools collected from NR-1025 (left) and R-1014 (right) subjects from HCC “cohort A.” (B) Schematic of experiment design of survival experiments on either C57BL6 WT GF or SPF mice pre-depleted with ABXs harboring MYC-lucOS;CTNNB1 tumors after FMT with blended stool generated from an R-donor (1014 subject) and an NR-donor (1025 subject). Schematic generated by BioRender. Survival curves from ex-GF mice harboring MYC-lucOS;CTNNB1 (C) or MYC-luc;CTNNB1 (D) tumors upon FMT with 1025-stool or 1014-stool. Abbreviations: ABXs, antibiotics; FMT, fecal microbiome transplant; GF, germ-free; HCC, hepatocellular carcinoma; HDTVI, hydrodynamic tail-vein injection; OVA, ovalbumin; SPF, specific pathogen-free; WT, wild type.

Article Snippet: Specific pathogen-free (SPF) C57BL/6 wild-type mice of 4–6-week-old were purchased from Envigo.

Techniques: Microbiome, Generated, Injection

Biological properties of dictamnine.

Journal: Molecules

Article Title: Dictamnine and Related Quinoline Alkaloids from Dictamnus : From Phytochemistry to Biological Activities and Toxicity

doi: 10.3390/molecules31213805

Figure Lengend Snippet: Biological properties of dictamnine.

Article Snippet: Antimicrobial , Human pathogenic microorganisms: Bacillus subtilis (ATCC 6633), Candida albicans (ATCC 10231), and Pseudomonas aeruginosa (ATCC 27853) , 8–128 μg/mL , Not investigated , Dictamnine exhibited moderate antimicrobial activity. , [ ] .

Techniques: Activity Assay